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1. Introduction 
The photoprotein aequorin (M r ~ 20 000) emits 
light in aqueous olutions when a trace amount of 
Ca 2+ is added, independently of the presence of O2 
[ 1,2]. Aequorin has been extensively used in detecting 
and monitoring Ca 2÷ in various biological systems, 
including single cells [2,3]. EDTA and EGTA have 
been used to preserve the luminescent activity of 
aequorin until its use, and they have been also used 
to prepare calcium-buffer solutions for calibrating the 
light emission of aequorin. 
We now report hat EDTA can inhibit the lumines- 
cence of aequorin by the binding of EDTA to the 
photoprotein, i  addition to the removal of Ca 2+ by 
chelation. Similar effects are expected for EGTA 
which is functionally similar to EDTA. 
We have also found that acylation of aequorin can 
change the luminescent kinetics of this photoprotein, 
thus opening possibilities for creating modified forms 
ofaequorin that are more suitable than native aequorin 
for the specific purposes of analysis. 
2. Materials and methods 
Aequorin was extracted and purified as in [4,5] 
and made to 0.1-0.2 mM stock solution in 5 mM 
MOPS (4-morph01inepropanesulfonic acid)-0.1 mM 
EDTA (pH 7.0), then stored frozen. EDTA (2 Na-salt), 
acetic anhydride, and 3-(p-hydroxyphenyl)propionic 
acid N-succinimide ster were purchased from Aldrich 
Chemicals, MOPS was from Sigma, sodium acetate 
'Ultrapure' from Alfa, Sephadex G-25-fine from 
Pharmacia, nd ethylenediamine tetra [2-14C]acetic 
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acid (108 mCi/mmol) from Amersham Radiochemical 
Centre. Deionized istilled water having a resistance 
of >20 MI2 was used throughout. Ca-EDTA (pH 7.0) 
50 mM, was prepared by titrating 100 mM EDTA 
with 100 mM CaC1 using arsenazo III (Sigma, grade I) 
as the indicator, with continuous adjustment of the 
pH with 5 M NaOH. Only plastics came into contact 
with solutions throughout the experiments, except a
5 #1 Hamilton syringe to measure aequorin samples 
and the glass tip of a combination pH electrode having 
a plastic body. 
MOPS buffer solutions without added EDTA were 
prepared with a stock solution of 50 mM MOPS that 
were pretreated with Chelex 100 (50-100 mesh, 
Bio-Rad Labs), as follows: 500 ml 50 mM MOPS 
(pH 10, adjusted with NaOH) was filtered through a
column of Chelex 100 (1.8 × 12 cm) pre-washed with 
2 1 water, and the last 300 ml of the filtrate was kept 
and used as the stock solution. The pH and pCa of 
MOPS buffer prepared with this stock solution were 
adjusted, respectively, with a diluted HCI that was 
prepared by dissolving HCI gas in water, and with 
CaC12. 
EDTA (10 mM)-MOPS (5 mM) calcium-buffers 
(pH 7.1) of pCa 8.05, 7.57, 7.04, 6.56, 6.1,5.54 and 
4.8 contained, respectively, the following percentages 
of Ca-EDTA in 10 mM of the total EDTA: 18, 40, 
69, 87, 95.1, 98.6 and 99.75 [6]. pCa 4 buffer con- 
tained 10 mM Ca-EDTA plus 0.1 mM CaC12 in addi- 
tion to 5 mM MOPS. 
To measure light intensity of aequorin lumines- 
cence, astock solution of aequorin or its derivative in 
0.1 mM EDTA was first diluted with water to reduce 
the EDTA level to 10/aM, then 1-3/11 of the diluted 
sample was placed in a polycarbonate t st tube, and 
luminescence was initiated by adding 2 ml of a test 
solution from a plastic syringe, at 23-25°C. 
Equilibrium dialysis was performed as follows: 
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1 ml 0.1 mM aequorin stock solution was placed in 
pre-washed cellulose tubing (inflated diam. 6.3 mm; 
A. H. Thomas Co.), and dialyzed against 50 ml 3 mM 
MOPS-50 mM NaC1-0.2, 1 or 5 mM EDTA (pH 7.0) 
that contained 6/aCi [ 14C] EDTA, with a magnetic 
stirrer, at 0-3°C. After 24 h, 0.3 ml each of the 
inside solution and the outside solution were taken .~ 
out and each was mixed with 20 pl 0.l M CaC12 and 
15 ml 'Aquafluor' (New England Nuclear). The radio- 
activities were then measured in a Packard liquid scin- o 
tillation counter at 8°C. The equilibration was com- o 
plete in a control experiment in which aequorin was o ~ 
omitted, although no effort was made to confirm the 
completeness in the presence of aequorin. 
p-Hydroxyphenylpropionyl aequorin (HPP- 
aequorin) was prepared as follows: To 1 ml 0.15 mM 
aequorin stock solution, 10 mg NaHCO3 was added, 
followed by a stepwise addition of 2% 3-(p-hydroxy- 
phenyl)propionic a id N-succinimide ester (in diox- 
ane) in 5 #1 portions at 0°C, monitoring the total 
luminescent capacity of aequorin by testing 2/~1 frac- 
tions of the reaction mixture with 10 mM calcium 
acetate. When four 5/A portions of the reagent were 
added in ~20 min, the luminescent capacity of 
aequorin decreased to 50% of the initial value. The 
mixture was immediately f'dtered through acolumn 
of Sephadex G-25 fine (1 × 8 cm; prepared with 
0.1 mM EDTA-5 mM MOPS (pH 7.0)) to separate 
the aequorin product from the reagent and its decom- 
position products. When needed, the protein was con- 
centrated through precipitation with (NH4)2SO4. 
Acetylated aequorin was prepared as follows: To 
0.6 ml 0.2 mM aequorin stock solution, 0.3 ml satu- 
rated aqueous olution of sodium acetate was added, 
followed by the addition of three 3/al portions of 
O acetic anhydride at 0 C. When the lummescent capac- 
ity of aequorin decreased to ~60% of the initial 
value, the mixture was fdtered through acolumn of 
Sephadex G-25 in the same manner as described above 
for 
3. Results and discussion 
The relation between light emission of aequorin 
and [Ca 2+] in various buffers is shown in rigA. The 
maximum slope of the log-log plot of light emission 
as a function of [Ca 2÷] was 2-3,  in agreement with 
[5,7-9]; the data suggest that the inclusion of EDTA 
in the buffers might have caused the increase of the 
maximum slope. 
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Fig.1. Relationship between [Ca 2÷] and initial maximum 
light intensity when 1 p110 pM aequorin was luminesced in 
buffers without added EDTA ( ) and with EDTA ( - - - ) .  
The buffers used and the maximum slope of the curves are 
(from the top curve): 1 mM sodium acetate (pH 5.8), slope 
2.05 (e); 5 mM MOPS (pH 7.1), slope 1.9 (o); 50 mM MOPS 
(pH 7.1), slope 2.05 (A); 0.1 mM EDTA-5 mM MOPS 
(pH 7.1), slope 2.8 (zx); 1 mM EDTA-5 mM MOPS (pH 7.1), 
slope 2.3 (m); 10 mM EDTA-5 mM MOPS (pH 7.1), slope 
2.2 (~). The lower light intensities inChelex 100-treated 
50 mM MOPS than in 5 mM MOPS suggest that Chelex 100 
had leached some calcium-chelating substance into the 
50 mM MOPS, as observed in [5 ]. The leached substance, as 
well as the EDTA initially present inthe aequorin sample and 
undetermined traces of contaminating calcium in the buffers, 
may cause rrors at pCa >7 in the absence of added EDTA, 
although this inaccuracy does not affect hese conclusions. 
Equilibrium dialysis of 0.1 mM aequorin in pH 7.1 
buffers containing 5 mM, 1 mM and 0.2 mM [14C]- 
EDTA resulted in the binding of 2.3, 1.9 and 1.0 mol 
EDTA/mol aequorin, respectively. The data clearly 
indicate the ability of aequorin to bind EDTA. No 
effort was made, however, to obtain the binding con- 
stant between EDTA and aequorin by this technique, 
due to the decreased stability of aequorin in EDTA 
solutions of lower concentration. 
The effect of Ca-EDTA on aequorin luminescence 
appears insignificant: luminescence ofaequorin in 
5 mM MOPS buffer (pH 7.1) containing 0.1 mM 
CaC12 was not appreciably inhibited by up to 50 mM 
Ca-EDTA buffer. 
202 
Volume 138, number 2 FEBS LETTERS February 1982 
12 
11 
A ~s  & 
e~,  ~ 
A 
s 
s 
. . /  "o" / 
A ~ • l / I  
A . . . .~_&~ • / 0  / 
0 • i I 
0_........0~... 0 * / 0  
A 
~,I0 
t -  
O 
g9 
_o 
o .o~O ~°~° 
O~O, . - - - - "  
I 
/ 
& I I 
I 
i I & 
& 
I 
I 
/ /  
/ 
1.5 
B 
~'o 1.0 
X 
-I" 
0.5 /"o 
ELI / 
/ 
/ 
/ 
/ 
t /  | 
0 1 
I 
I 
I 
/ 
I 
I g, 
I I I | ~ I I 1 I 
7 0 1 2 3 2 3 4 5 
[Oglo(dilution fo.ctor of lOmMEDTA buffer) [C J  ÷] x 10 6 (M) 
Fig.2. (A) Effect of the dilution of 10 mM EDTA-5 mM MOPS (pH 7.1) [pCa 5.54 (zx); 6.1 (o); and 6.56 (*)] with 5 mM MOPS 
(pH 7.1) on the initial ight intensity of 3 vl 10 vM aequorin. The 3 points on the right, connected with broken lines, were 
obtained with 5 mM MOPS containing CaCI 2 in amounts corresponding to the pCa values. (B) The data obtained with the solu- 
tions that contained <10 vM free EDTA (symbols with superscript dot in A) are plotted as in [11]. Abbreviations: EDTAf, free 
EDTA; L, initial ight intensity in the presence of EDTA; L o, initial ight intensity in absence of EDTA. 
When 10 mM EDTA calcium-buffers (pCa 5.54, 
6.1 and 6.56) each made in 5 mM MOPS buffer 
(pH 7.1) were stepwise diluted with 5 mM MOPS 
buffer (pH 7.1), a progressive increase in the lumines- 
cence intensity of added aequorin was noted (fig.2A). 
These data provide direct proof for the luminescent 
inhibitory effect of free EDTA through direct inter- 
action with aequorin. Deviation of pCa-values by 
dilfition (significant only at high dilutions) does not 
affect this conclusion. The inhibition of aequorin 
luminescence by EDTA is thus due to: 
(i) Removal of free Ca 2÷ by chelation; 
(ii) Inhibition by directly binding to aequorin. 
The data in fig.2A have been replotted by the 
Dixon method [10] taking the [free EDTA] vs the 
reciprocal of light intensity (l/L). Although aequorin 
is not an enzyme, such treatment should be justified 
if only initial light emission is considered. The plot, 
however, did not give the anticipated straight line; at 
>10/aM free EDTA, 1/1, increased much lower in 
proportion to the increase of [free EDTA]. The devia- 
tion from a straight line could be due to competition 
of free EDTA and non-inhibitory Ca-EDTA, although 
other explanations are possible. Extrapolation of the 
curve to the zero concentration of free EDTA to 
obtain the inhibitor constant is not justified because 
the error of data becomes greatest at the lowest [free 
EDTA]. 
When the data involving <10 gM free EDTA in 
fig.2A were replotted as in [11 ], an inhibitor con- 
stant, Ki, of ~2.7 X 10 -s M was obtained for free 
EDTA, as shown in fig.2B. In plotting this graph, 
corrections were not made for the shifts of pCa-values 
nor for the errors in [free EDTA] caused by greatly 
diluting the original 10 mM EDTA buffer solutions. 
This should not cause a large error in the K i as the 
dilution effects are negligibly small for pCa 6.56 
buffer, although discernible for pCa 6.1 buffer and 
significantly large for pCa 5.54 buffer. 
We have also found that acylation of aequorin can 
modify its luminescent kinetics (fig.3). The maximum 
slope of the log-log plot of light vs [Ca 2+] for 
p-hydroxyphenylpropionyl aequorin (HPP-aequo- 
fin) was 1.1 in contrast to 1.9 for native aequorin, 
both in 5 mM MOPS buffer (pH 7.1)without added 
EDTA. In the same buffer, luminescence ofacetylated 
aequorin was/>15-times higher than that of native 
aequorin over 10-s-10 -7 M Ca 2+ and reached a maxi- 
mum at >10 -7 M Ca 2+. 
In the presence of 0.1 mM EDTA buffer, lurnines- 
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luminescence of'aequofin. In detecting and monitoring 
Ca 2+ with aequorin, aspecific acylated aequorin should 
be chosen. 
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